EXAMINE (EXamination of CArdiovascular OutcoMes: AlogliptIN vs. Standard of CarE in Patients with Type 2 Diabetes Mellitus and Acute Coronary Syndrome)

THE FREEDOM TRIAL: ” Future Revascularisation Evaluation in patients with diabetes mellitus: Optimal management of multivessel disease”

Valentin Fuster et al

Anti-Inflammatory Therapy with Canakinumab for the Prevention and Management of Diabetes

Pablo Avanzas

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction (DAPA-HF) Study

Koji Hasegawa

Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes

Celso Amodeo

SGLT2 Inhibitors Reduce Blood Pressure and Left Ventricular Mass

Thomas Kahan